Ozon Pharmaceuticals completed the installation of equipment for production of APS

Ozon Pharmaceuticals Group completed the installation of industrial equipment on the production line for active pharmaceutical substances in Togliati. Installation of three 2000-liter bioreactors and chromatographs was completed. New lines will allow to produce up to 1 million vials of lyophilizates, 5 million prefilled syringes and more than 4 million vials of sterile solutions annually. Total investment in the project amounted to ₽0.8 billion. Sales of the first biotech drugs are scheduled to start in 2027.